(Q38113237)

29 August 2017

The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation (English)

1 reference

29 August 2017

0 references

1 reference

1 reference

Blazej Misiak

1

0 references

Dorota Frydecka

series ordinal

2

object named as

Dorota Frydecka

1 reference

29 August 2017

3

Patryk Piotrowski

1 reference

29 August 2017

4

Andrzej Kiejna

1 reference

PubMed ID

23750646

29 August 2017

language of work or name

1 reference

1 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

5

1 reference

29 August 2017

3

1 reference

29 August 2017

317-329

1 reference

A systematic review of the prevalence of schizophrenia

29 August 2017

1 reference

Mortality in schizophrenia: a measurable clinical endpoint

21 January 2018

1 reference

Excess mortality of schizophrenia. A meta-analysis

21 January 2018

1 reference

Mortality in schizophrenia

21 January 2018

1 reference

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

Metabolic syndrome associated with schizophrenia and atypical antipsychotics

21 January 2018

1 reference

Atypical antipsychotic-induced weight gain: insights into mechanisms of action

21 January 2018

1 reference

Hypothalamic dopamine and serotonin in the regulation of food intake.

21 January 2018

1 reference

Antipsychotic induced weight gain in schizophrenia:mechanisms and management

21 January 2018

1 reference

Obesity, serious mental illness and antipsychotic drugs.

21 January 2018

1 reference

Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis

21 January 2018

1 reference

Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients.

21 January 2018

1 reference

Metabolic risk factors in drug-naive patients with first-episode psychosis.

21 January 2018

1 reference

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia

21 January 2018

1 reference

The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela.

21 January 2018

1 reference

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

21 January 2018

1 reference

Relationship between metabolic syndrome and cognition in patients with schizophrenia.

21 January 2018

1 reference

One-carbon metabolism and schizophrenia: current challenges and future directions.

21 January 2018

1 reference

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study

21 January 2018

1 reference

MTHFR and risk of metabolic syndrome in patients with schizophrenia

21 January 2018

1 reference

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants

21 January 2018

1 reference

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics

21 January 2018

1 reference

Homocysteine and lipids: S-adenosyl methionine as a key intermediate

21 January 2018

1 reference

Elevated prenatal homocysteine levels as a risk factor for schizophrenia

21 January 2018

1 reference

Serum homocysteine and folate concentrations among a US cohort of adolescents before and after folic acid fortification

21 January 2018

1 reference

Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys

21 January 2018

1 reference

Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children: the Bogalusa Heart Study

21 January 2018

1 reference

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease

21 January 2018

1 reference

Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour

21 January 2018

1 reference

Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis

21 January 2018

1 reference

Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type

21 January 2018

1 reference

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics

21 January 2018

1 reference

Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia

21 January 2018

1 reference

Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism

21 January 2018

1 reference

The role of one-carbon metabolism in schizophrenia and depression

21 January 2018

1 reference

Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients

21 January 2018

1 reference

A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia

21 January 2018

1 reference

Pharmacogenetics and folate metabolism -- a promising direction

21 January 2018

1 reference

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

21 January 2018

1 reference

Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population.

21 January 2018

1 reference

Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.

21 January 2018

1 reference

Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene

21 January 2018

1 reference

Genetics in psychiatry: are the promises met?

21 January 2018

1 reference

Epigenetic choreographers of neurogenesis in the adult mammalian brain

21 January 2018

1 reference

Epigenetic regulation of neurogenesis in the adult mammalian brain

21 January 2018

1 reference

Epigenetic integration of the developing brain and face

21 January 2018

1 reference

Epigenetic regulation of neural cell differentiation plasticity in the adult mammalian brain

21 January 2018

1 reference

Epigenetic gene regulation in the adult mammalian brain: multiple roles in memory formation

21 January 2018

1 reference

Epigenetic mechanisms in experience-driven memory formation and behavior

21 January 2018

1 reference

CHD1 remodels chromatin and influences transient DNA methylation at the clock gene frequency.

21 January 2018

1 reference

Chromatin remodeling and the circadian clock: Jumonji C-domain containing proteins

21 January 2018

1 reference

Epigenetic effects of stress and corticosteroids in the brain

21 January 2018

1 reference

An epigenetic blockade of cognitive functions in the neurodegenerating brain

21 January 2018

1 reference

Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.

21 January 2018

1 reference

Assessment of chromosomal imbalances in CIMP-high and CIMP-low/CIMP-0 colorectal cancers.

21 January 2018

1 reference

Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future

21 January 2018

1 reference

Epigenetic profiling in schizophrenia and major mental disorders

21 January 2018

1 reference

Epigenomic profiling reveals DNA-methylation changes associated with major psychosis

21 January 2018

1 reference

Histone modifications, DNA methylation, and schizophrenia

21 January 2018

1 reference

Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation

21 January 2018

1 reference

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

21 January 2018

1 reference

Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia

21 January 2018

1 reference

Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report

21 January 2018

1 reference

Neocortical RELN promoter methylation increases significantly after puberty

21 January 2018

1 reference

Reelin promoter hypermethylation in schizophrenia

21 January 2018

1 reference

S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis

21 January 2018

1 reference

DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia.

21 January 2018

1 reference

Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.

21 January 2018

1 reference

FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies

21 January 2018

1 reference

Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders.

21 January 2018

1 reference

The epigenetics of suicide: explaining the biological effects of early life environmental adversity

21 January 2018

1 reference

Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection.

21 January 2018

1 reference

DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains

21 January 2018

1 reference

Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins.

21 January 2018

1 reference

DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.

21 January 2018

1 reference

Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia

21 January 2018

1 reference

Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research

21 January 2018

1 reference

Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.

21 January 2018

1 reference

Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder.

21 January 2018

1 reference

Methylation and QTDT analysis of the 5-HT2A receptor 102C allele: analysis of suicidality in major psychosis

21 January 2018

1 reference

Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset

21 January 2018

1 reference

Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia.

21 January 2018

1 reference

Methylation analysis of the NOTCH4 -25 C/T polymorphism in schizophrenia

21 January 2018

1 reference

A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals

21 January 2018

1 reference

DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia.

21 January 2018

1 reference

Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia

21 January 2018

1 reference

Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

21 January 2018

1 reference

Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins.

21 January 2018

1 reference

Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder

21 January 2018

1 reference

Epigenetic priming of the metabolic syndrome.

21 January 2018

1 reference

Epigenetic changes in early life and future risk of obesity.

21 January 2018

1 reference

Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects?

21 January 2018

1 reference

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

21 January 2018

1 reference

DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences

21 January 2018

1 reference

LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes

21 January 2018

1 reference

Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment

21 January 2018

1 reference

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

21 January 2018

1 reference

Valproate induces DNA demethylation in nuclear extracts from adult mouse brain

21 January 2018

1 reference

Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia.

21 January 2018

1 reference

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.

21 January 2018

1 reference

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/EPI.13.22

1 reference

29 August 2017

1 reference

PubMed ID

23750646